Earnings Feed
Start Free
ROWE COMPANIES·4

Apr 11, 12:29 PM ET

MORPHIS GENE S 4

4 · ROWE COMPANIES · Filed Apr 11, 2005

Insider Transaction Report

Form 4
Period: 2005-04-07
ROWE COMPANIESROW
MORPHIS GENE S
Chief Financial Officer
Transactions
  • Award

    Option to Purchase

    2005-04-07$3.96/sh+15,000$59,400→ 40,000 total
    Exercise: $3.96From: 2005-04-07Exp: 2015-04-07→ common (15,000 underlying)
Holdings

  • Option to purchase

    Exercise: $2.15From: 2002-12-03Exp: 2012-12-03→ common (1,334 underlying)
    1,334

  • Option to purchase

    Exercise: $2.15From: 2003-12-03Exp: 2012-12-03→ common (1,333 underlying)
    4,001

  • Option to purchase

    Exercise: $1.95From: 2004-07-30Exp: 2012-07-30→ common (5,000 underlying)
    13,000

  • Option to Purchase

    Exercise: $3.00From: 2003-12-01Exp: 2013-12-01→ common (12,000 underlying)
    25,000

  • Common Stock

    33,000

  • Option to purchase

    Exercise: $2.15From: 2003-06-03Exp: 2012-12-03→ common (1,334 underlying)
    2,668

  • Option to purchase

    Exercise: $2.15From: 2004-12-03Exp: 2012-12-03→ common (1,333 underlying)
    6,667

  • Option to purchase

    Exercise: $2.15From: 2005-06-03Exp: 2012-12-03→ common (1,333 underlying)
    8,000

  • Option to purchase

    Exercise: $2.15From: 2004-06-03Exp: 2012-12-03→ common (1,333 underlying)
    5,334

Documents

1 file
  • 4
    rrd75373.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP